“Stem Cell Contract Development and Manufacturing Services (CDMO) are supported by a professional team that assists in process design and project management, providing comprehensive services for regenerative medicine product development. These services cover: selection of research or GMP clinical sites, product construction, small-scale production of investigational cells or exosome-based drugs, production process design, establishment of raw material data, large-scale/commercial production, implementation of specialized processes/equipment, aseptic filling, packaging, and GDP-compliant transportation.
Through a flexible and customized collaboration model, combined with the expertise of the GWOXI professional team, we help clients enhance product market competitiveness, effectively reduce production line investment costs, and accelerate product launch and commercialization. This allows clients to focus on their brand core and seize market opportunities more efficiently.
✅ Manufacturing Facilities Compliant with PIC/S GMP Standards
✅ Core Processes and Patented Technologies
✅ Experienced Professional Team
✅ Highest Standard Quality Control
1. Inquiry for Requirements
Provide sample information and manufacturing requirements, which the Tracker King team will evaluate for process feasibility and conduct preliminary planning.
2. Sign the Service Agreement
Confirm technical specifications, schedule, and costs, and execute the confidentiality and contract manufacturing agreement.
3. Sample Reception and Preprocessing
Performed according to SOP: tissue sample reception, inspection, and pre-processing prior to cell isolation.
4. Cell Therapy Product Manufacturing and Testing
Perform cell culture, preparation, quality testing, and final packaging.
5. Product Delivery and Technical Documentation Reporting
Deliver the formulation and provide comprehensive batch manufacturing and testing reports.
For further inquiries regarding collaboration or quotation, please feel free to contact us!
The required time varies depending on the scope of the contract and may be influenced by factors such as cell source, process development, and customized specifications.
1. GWOXI possesses cell resources and technologies that meet clinical standards, and can provide non-exclusive stem cell licensing to accelerate product compliance with regulatory requirements.
2. Cell therapy manufacturing facilities compliant with PIC/S GMP standards, reducing the time and financial costs for partners to establish their own facilities.
3. GWOXI possesses mature stem cell application technologies, providing high-yield and consistently high-quality processes and products, becoming a long-term partner for clients.
4. Products (formulations) are released after comprehensive evaluation according to TAF-accredited testing standards, ensuring partners can confidently advance to clinical applications.
5. Uphold mutual confidentiality principles to protect the market potential of partners’ developed products.